Skip to main content
. Author manuscript; available in PMC: 2016 Dec 15.
Published in final edited form as: Psychiatry Res. 2015 Dec 15;230(2):545–552. doi: 10.1016/j.psychres.2015.10.002

Table 4.

Relation of relative telomere length to the likelihood of membership in latent classes of phobic symptom scores in 2004 (N=3,194)a,b

Relative Telomere Length (z-scores)
Quartile 1-Quartile 3
OR (95% CI)		 Quartile 4 (longest)
OR (95% CI)		 P value
Model Ic
 Minimal/intermediate 0.91 (0.74-1.11) 1.00 (ref) 0.34
 Severe 1.78 (0.92-3.44) 1.00 (ref) 0.09
Model IId
 Minimal/intermediate 0.95 (0.76-1.17) 1.00 (ref) 0.60
 Severe 1.78 (0.91-3.51) 1.00 (ref) 0.09
Model IIIe
 Minimal/intermediate 0.95 (0.77-1.18) 1.00 (ref) 0.65
 Severe 1.76 (0.90-3.47) 1.00 (ref) 0.10

Abbreviations: OR=odds ratio. CI=confidence interval.

a

Polytomous regression analysis conducted across three mutually exclusive classes of Crown-Crisp Index (CCI) scores in 2004: 1) women with severe CCI in 2004 (N=80), 2) women with minimal/intermediate CCI in 2004 (N=2,436), and 3) women who were non-anxious in 2004 (N=678) (reference).

b

All women had no meaningful anxiety symptoms at baseline (CCI=0-3).

c

Adjusted for age (continuous, in years).

d

Adjusted for model I covariates plus CCI in 1988 (continuous), body mass index (BMI) (continuous, in kg/m2), physical activity (continuous, MET-hours/week), pack years of smoking (continuous), paternal age at participant’s birth (15 to <25 years, 25 to <30 years, 30 to <35 years, 35 to <40 years, ≥40 years, missing), antidepressant use (no, yes, missing), race (non-Hispanic white, other), and education (RN, bachelor, graduate degree).

e

Adjusted for model II covariates plus hypertension (yes, no), dyslipidemia (yes, no), diabetes (yes, no), cardiovascular disease (yes, no), respiratory disease (yes, no) and cancer (yes, no).